![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 38/24 | |
A61K 35/30 | |||
A61P 25/28 |
(11) | Number of the document | 1740202 |
(13) | Kind of document | T |
(96) | European patent application number | 05706487.5 |
Date of filing the European patent application | 2005-02-14 | |
(97) | Date of publication of the European application | 2007-01-10 |
(45) | Date of publication and mention of the grant of the patent | 2012-05-09 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/CA2005/000184 |
Date | 2005-02-14 |
(87) | Number | WO 2005/077404 |
Date | 2005-08-25 |
(30) | Number | Date | Country code |
544915 P | 2004-02-13 | US |
(72) |
WEISS, Samuel, CA
ENWERE, Emeka, CA
ANDERSEN, Linda, CA
GREGG, Christopher, CA
|
(73) |
Stem Cell Therapeutics Corp.,
Bow Valley Square III 255 5th Avenue SW Suite 500, Calgary, AB T2P 3G6,
CA
|
(54) | USE OF LUTEINIZING HORMONE (LH) AND CHORIONIC GONADOTROPIN (HCG) FOR PROLIFERATION OF NEURAL STEM CELLS AND NEUROGENESIS |
USE OF LUTEINIZING HORMONE (LH) AND CHORIONIC GONADOTROPIN (HCG) FOR PROLIFERATION OF NEURAL STEM CELLS AND NEUROGENESIS |